S&P 500   3,940.18 (-0.03%)
DOW   33,649.16 (+0.16%)
QQQ   281.12 (-0.20%)
AAPL   141.27 (-1.15%)
MSFT   245.44 (+0.13%)
META   114.00 (-0.11%)
GOOGL   95.69 (-1.33%)
AMZN   88.69 (+0.50%)
TSLA   174.24 (-3.10%)
NVDA   160.36 (+0.31%)
NIO   12.58 (-4.98%)
BABA   88.81 (-2.89%)
AMD   70.41 (+0.20%)
T   19.38 (+1.10%)
MU   53.44 (-0.45%)
CGC   3.31 (-8.31%)
F   13.22 (-0.45%)
GE   85.53 (+0.29%)
DIS   92.45 (+0.17%)
AMC   6.21 (-8.00%)
PYPL   74.93 (+3.74%)
PFE   50.50 (+1.59%)
NFLX   306.54 (+0.32%)
S&P 500   3,940.18 (-0.03%)
DOW   33,649.16 (+0.16%)
QQQ   281.12 (-0.20%)
AAPL   141.27 (-1.15%)
MSFT   245.44 (+0.13%)
META   114.00 (-0.11%)
GOOGL   95.69 (-1.33%)
AMZN   88.69 (+0.50%)
TSLA   174.24 (-3.10%)
NVDA   160.36 (+0.31%)
NIO   12.58 (-4.98%)
BABA   88.81 (-2.89%)
AMD   70.41 (+0.20%)
T   19.38 (+1.10%)
MU   53.44 (-0.45%)
CGC   3.31 (-8.31%)
F   13.22 (-0.45%)
GE   85.53 (+0.29%)
DIS   92.45 (+0.17%)
AMC   6.21 (-8.00%)
PYPL   74.93 (+3.74%)
PFE   50.50 (+1.59%)
NFLX   306.54 (+0.32%)
S&P 500   3,940.18 (-0.03%)
DOW   33,649.16 (+0.16%)
QQQ   281.12 (-0.20%)
AAPL   141.27 (-1.15%)
MSFT   245.44 (+0.13%)
META   114.00 (-0.11%)
GOOGL   95.69 (-1.33%)
AMZN   88.69 (+0.50%)
TSLA   174.24 (-3.10%)
NVDA   160.36 (+0.31%)
NIO   12.58 (-4.98%)
BABA   88.81 (-2.89%)
AMD   70.41 (+0.20%)
T   19.38 (+1.10%)
MU   53.44 (-0.45%)
CGC   3.31 (-8.31%)
F   13.22 (-0.45%)
GE   85.53 (+0.29%)
DIS   92.45 (+0.17%)
AMC   6.21 (-8.00%)
PYPL   74.93 (+3.74%)
PFE   50.50 (+1.59%)
NFLX   306.54 (+0.32%)
S&P 500   3,940.18 (-0.03%)
DOW   33,649.16 (+0.16%)
QQQ   281.12 (-0.20%)
AAPL   141.27 (-1.15%)
MSFT   245.44 (+0.13%)
META   114.00 (-0.11%)
GOOGL   95.69 (-1.33%)
AMZN   88.69 (+0.50%)
TSLA   174.24 (-3.10%)
NVDA   160.36 (+0.31%)
NIO   12.58 (-4.98%)
BABA   88.81 (-2.89%)
AMD   70.41 (+0.20%)
T   19.38 (+1.10%)
MU   53.44 (-0.45%)
CGC   3.31 (-8.31%)
F   13.22 (-0.45%)
GE   85.53 (+0.29%)
DIS   92.45 (+0.17%)
AMC   6.21 (-8.00%)
PYPL   74.93 (+3.74%)
PFE   50.50 (+1.59%)
NFLX   306.54 (+0.32%)
Top-Rated Stocks  
NYSE:BSX

Boston Scientific - BSX Stock Forecast, Price & News

$45.57
+0.41 (+0.91%)
(As of 12/7/2022 01:40 PM ET)
Add
Compare
Today's Range
$45.35
▼
$45.90
50-Day Range
$38.14
▼
$46.60
52-Week Range
$34.98
▼
$47.49
Volume
69,601 shs
Average Volume
5.35 million shs
Market Capitalization
$65.27 billion
P/E Ratio
108.50
Dividend Yield
N/A
Price Target
$47.71

Boston Scientific MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.1% Upside
$47.71 Price Target
Short Interest
Healthy
0.92% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.86
Upright™ Environmental Score
News Sentiment
0.12mentions of Boston Scientific in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$12.61 M Sold Last Quarter
Proj. Earnings Growth
10.98%
From $1.73 to $1.92 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.50 out of 5 stars

Medical Sector

161st out of 1,027 stocks

Surgical & Medical Instruments Industry

17th out of 101 stocks

See Top Rated MarketRank™ Stocks Here
BSX stock logo

About Boston Scientific (NYSE:BSX) Stock

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Stock News Headlines

November 13, 2022 | marketbeat.com
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
December 5, 2022 | seekingalpha.com
Boston Scientific: Price Correction Coming
December 3, 2022 | americanbankingnews.com
Boston Scientific Co. (NYSE:BSX) Director Sells $809,176.12 in Stock
December 3, 2022 | americanbankingnews.com
Brokerages Set Boston Scientific Co. (NYSE:BSX) Target Price at $47.71
December 2, 2022 | msn.com
Boston Scientific's Return on Invested Capital Insights
November 30, 2022 | msn.com
Boston Scientific Strikes $615 Million Deal to Buy Medical Tech Firm Apollo Endosurgery
November 30, 2022 | bizjournals.com
Boston Scientific shelling out $615M for Apollo Endosurgery
November 29, 2022 | msn.com
Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham
November 29, 2022 | msn.com
Apollo Endosurgery (APEN) Stock Soars 65% on Boston Scientific Deal
November 29, 2022 | msn.com
Police discover remains of 4 infants in Boston apartment
November 29, 2022 | msn.com
Bodies of 4 infants found at Boston residence, police say
November 29, 2022 | finance.yahoo.com
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
November 29, 2022 | msn.com
Remains of 4 infants found in South Boston home earlier this month
November 28, 2022 | msn.com
Police await autopsy results on 4 infants found inside South Boston home
November 28, 2022 | msn.com
Golden Cross Appears Before Boston Scientific Investors
November 28, 2022 | msn.com
Here’s what Prince William and Princess Kate will do in Boston this week
November 27, 2022 | celticswire.usatoday.com
Celtics offense erupts as Boston grabs 130-121 victory against Washington
November 27, 2022 | markets.businessinsider.com
BSX : Post-market Study Data Reinforce Success & Safety Of ACURATE Neo2 Aortic Valve System
November 27, 2022 | msn.com
Boston injured in No. 1 Gamecocks’ 85-38 win over Hampton
November 27, 2022 | apnews.com
Boston hurt in No. 1 Gamecocks’ win; No. 3 UConn tops Iowa
November 27, 2022 | forbes.com
Jayson Tatum Is The Boston Celtics’ MVP But It’s Too Early To Start Talking League MVP
November 27, 2022 | msn.com
Dennis Johnson Already Had a Boston Celtics Connection Before Joining the Team in 1983
November 27, 2022 | msn.com
Five Takeaways: Syracuse 32 Boston College 23
November 27, 2022 | sportsbookwire.usatoday.com
Boston University at Milwaukee odds, tips and betting trends
November 26, 2022 | msn.com
Man hit by vehicle in Nashua on Thanksgiving taken to Boston hospital
See More Headlines
Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Company Calendar

Last Earnings
10/26/2022
Today
12/07/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/01/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:BSX
CUSIP
10113710
CIK
885725
Web
www.bostonscientific.com
Phone
(508) 683-4000
Fax
508-683-5675
Employees
41,000
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$47.71
High Stock Price Forecast
$51.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+4.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
15 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.42
Trailing P/E Ratio
108.50
Forward P/E Ratio
26.34
P/E Growth
2.54
Net Income
$1.04 billion
Net Margins
5.19%
Pretax Margin
6.88%
Return on Equity
14.55%
Return on Assets
7.72%

Debt

Debt-to-Equity Ratio
0.49
Current Ratio
1.45
Quick Ratio
0.95

Sales & Book Value

Annual Sales
$11.89 billion
Price / Sales
5.49
Cash Flow
$2.71 per share
Price / Cash Flow
16.79
Book Value
$11.66 per share
Price / Book
3.91

Miscellaneous

Outstanding Shares
1,432,310,000
Free Float
1,422,858,000
Market Cap
$65.27 billion
Optionable
Optionable
Beta
0.85

Social Links


Key Executives

  • Mr. Michael F. MahoneyMr. Michael F. Mahoney (Age 57)
    Chairman, Pres & CEO
    Comp: $3.83M
  • Mr. Daniel J. BrennanMr. Daniel J. Brennan (Age 56)
    Exec. VP & CFO
    Comp: $1.4M
  • Mr. Joseph M. Fitzgerald (Age 58)
    Exec. VP & Group Pres of Cardiology
    Comp: $1.57M
  • Mr. Jeffrey B. MirvissMr. Jeffrey B. Mirviss (Age 56)
    Exec. VP & Pres of Peripheral Interventions
    Comp: $1.21M
  • Mr. John Bradley SorensonMr. John Bradley Sorenson (Age 54)
    Exec. VP of Global Operations
  • Mr. Jonathan R MonsonMr. Jonathan R Monson
    VP, Global Controller & Chief Accounting Officer
  • Ms. Jodi Euerle EddyMs. Jodi Euerle Eddy (Age 49)
    Sr. VP and Chief Information & Digital Officer
  • Ms. Susan Vissers Lisa (Age 53)
    VP of Investor Relations
  • Mr. Vance R. Brown
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Ms. Catherine Jennings
    VP of Global Marketing & New Bus. Devel. of Peripheral Interventions

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













BSX Stock - Frequently Asked Questions

Should I buy or sell Boston Scientific stock right now?

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last twelve months. There are currently 1 hold rating, 13 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BSX shares.
View BSX analyst ratings or view top-rated stocks.

What is Boston Scientific's stock price forecast for 2023?

15 Wall Street analysts have issued 1 year target prices for Boston Scientific's stock. Their BSX share price forecasts range from $43.00 to $51.00. On average, they expect the company's stock price to reach $47.71 in the next year. This suggests a possible upside of 5.7% from the stock's current price.
View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.

How have BSX shares performed in 2022?

Boston Scientific's stock was trading at $42.48 on January 1st, 2022. Since then, BSX stock has increased by 6.3% and is now trading at $45.16.
View the best growth stocks for 2022 here.

Are investors shorting Boston Scientific?

Boston Scientific saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 13,910,000 shares, a decrease of 8.6% from the October 15th total of 15,220,000 shares. Based on an average trading volume of 7,010,000 shares, the short-interest ratio is presently 2.0 days.
View Boston Scientific's Short Interest.

When is Boston Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our BSX earnings forecast.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) released its quarterly earnings data on Wednesday, October, 26th. The medical equipment provider reported $0.43 earnings per share for the quarter, missing analysts' consensus estimates of $0.44 by $0.01. The medical equipment provider had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.14 billion. Boston Scientific had a net margin of 5.19% and a trailing twelve-month return on equity of 14.55%. The company's revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.41 earnings per share.
Read the conference call transcript.

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific issued an update on its fourth quarter 2022 earnings guidance on Wednesday, November, 2nd. The company provided earnings per share guidance of $0.45-$0.48 for the period, compared to the consensus EPS estimate of $0.49. The company issued revenue guidance of $3.19 billion-$3.25 billion, compared to the consensus revenue estimate of $3.32 billion.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.16%), Primecap Management Co. CA (2.63%), Bollard Group LLC (1.80%), Artisan Partners Limited Partnership (1.40%), Bank of New York Mellon Corp (1.05%) and Lazard Asset Management LLC (0.88%). Insiders that own company stock include Desiree Ralls-Morrison, Michael F Mahoney, William F Bruss, Jeffrey B Mirviss, Scott Olson, John Bradley Sorenson, Daniel J Brennan, David S Wichmann, Arthur C Butcher, Jodi Euerle Eddy, Edward F Mackey, Wendy Carruthers, Jonathan Monson, David A Pierce, Eric Francis Yves Thepaut, Maulik Nanavaty, Ian T Meredith, Jeffrey B Mirviss, Nelda J Connors, Meghan Scanlon, Michael F Mahoney, David A Pierce and Joseph Michael Fitzgerald.
View institutional ownership trends.

How do I buy shares of Boston Scientific?

Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $45.16.

How much money does Boston Scientific make?

Boston Scientific (NYSE:BSX) has a market capitalization of $64.68 billion and generates $11.89 billion in revenue each year. The medical equipment provider earns $1.04 billion in net income (profit) each year or $0.42 on an earnings per share basis.

How many employees does Boston Scientific have?

The company employs 41,000 workers across the globe.

Does Boston Scientific have any subsidiaries?
The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.
Read More
How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The official website for the company is www.bostonscientific.com. The medical equipment provider can be reached via phone at (508) 683-4000, via email at bsxinvestorrelations@bsci.com, or via fax at 508-683-5675.

This page (NYSE:BSX) was last updated on 12/7/2022 by MarketBeat.com Staff